Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06191939 · ClinicalTrials.gov registry record · NA

Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma

A NA study of Lung Cancer, sponsored by Loyola Marymount University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06191939: Recruiting NA study of Lung Cancer, sponsored by Loyola Marymount University.

NCT06191939 is a NA study of Lung Cancer that is actively recruiting participants, run by Loyola Marymount University. The registered enrollment target is 60 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06191939, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Loyola Marymount University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot clinical trial is to test a disease-tailored, mindfulness-based intervention (Mindful Self-Compassion for Lung Cancer; MSC-LC) in adults diagnosed with lung cancer who are experiencing stigma. The current project seeks to: * Evaluate preliminary evidence for the feasibility, acceptability, and preliminary efficacy of MSC-LC in reducing stigma for adults with lung cancer, compared to a waitlist control condition * Elicit interventional impact not captured through quantitative measures with qualitative data from purposively sampled high responders and non-responders from the intervention condition Participants will randomized to either the MSC-LC intervention (a 10-week, virtually-delivered, group-based psychosocial intervention focused on the development of mindfulness and self-compassion skills) or to a waitlist control group that receives a referral to an NCI list of helpful mental health resources in their community. Researchers will compare the intervention and control groups to see if the MSC-LC intervention reduces lung cancer stigma and increases self-compassion.

Primary Outcome

The Lung Cancer Stigma Inventory is a self-report questionnaire of lung cancer stigma, which includes 25 items rated on a 5-point Likert scale. Scores range from 25-125, with higher scores indicating higher lung cancer stigma.

Conditions Studied

Interventions

  • BEHAVIORAL Mindful Self-Compassion for Lung Cancer (MSC-LC)
  • OTHER Enhanced standard of care with waitlist

Study Locations (1)

California

  • Loyola Marymount University - Los Angeles

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-05-06
Est. Completion 2026-01-12
Phase NA
Loyola Marymount University

7 total trials

What NCT06191939 shows while recruiting

NCT06191939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Mindful Self-Compassion for Lung Cancer (MSC-LC) is the first listed.

NCT06191939 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06191939 about?

NCT06191939 is a clinical study titled "Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma". The goal of this pilot clinical trial is to test a disease-tailored, mindfulness-based intervention (Mindful Self-Compassion for Lung Cancer; MSC-LC) in adults diagnosed with lung cancer who are experiencing stigma. The current project seeks to: * Evaluate preliminary evidence for the feasibility, ...

What is the current status of trial NCT06191939?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-05-06. Estimated completion is 2026-01-12.

What conditions does trial NCT06191939 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06191939?

The interventions under investigation include: Mindful Self-Compassion for Lung Cancer (MSC-LC) (BEHAVIORAL), Enhanced standard of care with waitlist (OTHER).

Who is sponsoring clinical trial NCT06191939?

This trial is sponsored by Loyola Marymount University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06191939 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06191939's enrollment target sits among peer trials

60 244th of 409 higher than 159 of 409 other Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06191939, the US trial registry maintained by the National Library of Medicine. NCT06191939 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.